Stock A293780 APTABIO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart AptaBio Therapeutics Inc.

Equities

A293780

KR7293780003

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
6,430 KRW -4.32% Intraday chart for AptaBio Therapeutics Inc. -13.34% -28.95%
2023 AptaBio Therapeutics Inc. announced that it has received KRW 49.999966652 billion in funding CI
2023 AptaBio Therapeutics Inc. announced that it expects to receive KRW 49.999966652 billion in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APTABIO THERAPEUTICS INC. Stock AptaBio Therapeutics Inc.
 104M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. A293780 Stock
  4. Charts AptaBio Therapeutics Inc.
  5. Sector Chart